News | Treatment Planning | January 30, 2018

Treatment planning system will be employed at U.K. hospitals for 3-D-CRT, IMRT, VMAT and other adaptive planning applications

RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital

January 30, 2018 — Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for two sites in London: Charing Cross Hospital and Hammersmith Hospital. RayStation was selected following a thorough evaluation of all potential treatment planning systems on the market.

The Imperial College Healthcare NHS Trust operates five hospitals in London, plus a range of community health services. Its radiation therapy services are provided at Charing Cross Hospital and Hammersmith Hospital. RayStation will replace two different treatment planning systems currently in use at the hospitals.

The two hospitals will use RayStation for all radiation therapy treatment planning activities, as well as all pre-treatment virtual simulation. RayStation will replace the hospitals’ current standalone system for virtual simulation. The purchase comprises a broad range of functionality, including three-dimensional conformal radiation therapy (3-D-CRT), intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), multi-criteria optimization (MCO), automated breast planning and adaptive planning.

RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines features such as MCO tools with full support for 4-D adaptive radiation therapy. It also includes functionality such as RaySearch’s algorithms for IMRT and VMAT optimization, and highly accurate dose engines for photon, electron, proton and carbon ion therapy.

For more information: www.raysearchlabs.com

 


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now